DUBLIN, Ireland - A leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry, is to create 170 remote jobs throughout Ireland.

The company is recruiting in the areas of medical information and pharmacovigilance in support of the commercial launch of vaccines indicated for COVID-19.

Recent graduates and seasoned professionals interested in making a worthwhile contribution to the global fight against COVID-19 are being encouraged to apply.

With recruitment under way, the company, IQVIA says it expects to fill the jobs before the end of March 2021, though there is potential for more roles to be created as the year progresses.

"There have been some positive indications recently regarding the potential for a COVID-19 vaccine and although there is still some way to go, it's important that we plan now. IQVIA is doing excellent work on drug safety and I am really pleased to see that they are creating an additional 170 jobs, specifically to prepare for coronavirus vaccines. It is encouraging that these roles will be available to staff working remotely," Tnaiste and Minister for Enterprise, Trade and Employment Leo Varadkar said Wednesday.

Head of Pharmacovigilance Oversight and Analytics for IQVIA Ireland, Barry Mulchrone added: "We are proud to play a role in the humanitarian effort to ensure the safety profile of vaccines used for COVID-19 are monitored to the highest international standards. With more than two decades of experience monitoring the safety of medicines globally, our company in Ireland is well positioned to play its part in addressing the current global pandemic."

Present in Ireland since 1990, IQVIA pioneered the country as a hub for clinical research. The additional positions will help IQVIA's capability to fight the pandemic, ensuring vaccines administrated post authorization are safe for the public. In addition to supporting life sciences in their clinical efforts across Europe and the globe, IQVIA's activity in Ireland includes supporting the life sciences industry from R&D through to commercialization, as well as healthcare providers, to improve treatment outcomes and patient pathways.